COPENHAGEN, Denmark--(BUSINESS WIRE)--Jan 10, 2020--

Today, Octarine Bio IVS (“Octarine” or the “Company”), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial fermentation announce a successful fundraising from private investors including Oskare Capital and Canopy Growth Cooperation (“Canopy Growth”) former CEO and founder Bruce Linton. Canopy Growth was the first cannabis producing company in North America to be listed on a major stock exchange (TSX), included on a major stock index (S&P/TSX Composite Index) and to list on the New York Stock Exchange.

“We’re thrilled to have the backing of a pioneer in the cannabis industry” says Nethaji Gallage, CEO of Octarine. “Bruce’s expertise, network, and knowledge will be a valuable asset to us, and we look forward to accelerating our technology with his and our other private investors’ support”.

“Octarine is a promising young company with a platform technology that can accelerate several rapidly evolving sectors, including work on synthesizing rare and novel cannabinoids” says Bruce Linton. “I look forward to supporting the Company and seeing their technology utilized in the market”.

The new funds will be used to strengthen the Company’s existing intellectual property and to demonstrate the commercial scalability of its fermentation-based production platform. Octarineis currently raising a seed round expected to close in early 2020.

About Octarine

Octarine’s mission is harnessing synthetic biology to develop rare and functionally superior cannabinoids and psilocybin derivatives targeting the pharmaceutical industry to improve the health and well-being of people worldwide. Octarine has developed in-cell enzymatic platforms expanding the chemical diversity of cannabinoids and psychedelic tryptamine derivatives facilitating the production of superior molecules with improved pharmacokinetic properties.

For more information visit www.octarinebio.com

About Bruce Linton

Mr. Linton is the founder and former CEO of Canopy Growth and co-founder of Tweed Marijuana Incorporated. Under Mr. Linton's leadership, Canopy Growth was the first cannabis producing company in North America to be listed on a major stock exchange. Mr. Linton held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp., and part of the establishing team at CrossKeys Systems Corporation ("CrossKeys"). He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys.

CONTACT: Nethaji Gallage, Octarine CEO

+4527639353

KEYWORD: DENMARK EUROPE

INDUSTRY KEYWORD: BIOTECHNOLOGY ALTERNATIVE MEDICINE PHARMACEUTICAL HEALTH

SOURCE: Octarine Bio

Copyright Business Wire 2020.

PUB: 01/10/2020 05:00 AM/DISC: 01/10/2020 05:01 AM

Copyright Business Wire 2020.